Dawn J. Caster

2.3k total citations · 1 hit paper
33 papers, 694 citations indexed

About

Dawn J. Caster is a scholar working on Nephrology, Rheumatology and Immunology. According to data from OpenAlex, Dawn J. Caster has authored 33 papers receiving a total of 694 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Nephrology, 18 papers in Rheumatology and 8 papers in Immunology. Recurrent topics in Dawn J. Caster's work include Renal Diseases and Glomerulopathies (17 papers), Systemic Lupus Erythematosus Research (17 papers) and Chronic Kidney Disease and Diabetes (8 papers). Dawn J. Caster is often cited by papers focused on Renal Diseases and Glomerulopathies (17 papers), Systemic Lupus Erythematosus Research (17 papers) and Chronic Kidney Disease and Diabetes (8 papers). Dawn J. Caster collaborates with scholars based in United States, Netherlands and Japan. Dawn J. Caster's co-authors include David W. Powell, Cristina Arriens, Laura Lisk, Samir V. Parikh, Y K Onno Teng, Simrat Randhawa, Ellen M. Ginzler, Keisha L. Gibson, Robert B. Huizinga and Brad H. Rovin and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Dawn J. Caster

33 papers receiving 681 citations

Hit Papers

Efficacy and safety of voclosporin versus placebo for lup... 2021 2026 2022 2024 2021 50 100 150 200 250

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawn J. Caster United States 13 432 309 241 111 109 33 694
Allen R. Hendricks United States 8 600 1.4× 239 0.8× 446 1.9× 62 0.6× 155 1.4× 16 913
Jared Hassler United States 5 601 1.4× 249 0.8× 448 1.9× 56 0.5× 153 1.4× 7 898
Daniel Brandt United States 8 404 0.9× 240 0.8× 499 2.1× 46 0.4× 58 0.5× 12 872
Tania Gonzalez‐Rivera United States 6 336 0.8× 138 0.4× 305 1.3× 34 0.3× 87 0.8× 10 554
Yukimasa Hisada Japan 10 203 0.5× 223 0.7× 234 1.0× 52 0.5× 22 0.2× 18 596
Tatsuya Atsumi Japan 14 529 1.2× 106 0.3× 197 0.8× 34 0.3× 161 1.5× 31 754
Chikako Segawa Japan 6 194 0.4× 152 0.5× 176 0.7× 58 0.5× 17 0.2× 10 422
C T Ravirajan United Kingdom 18 621 1.4× 112 0.4× 624 2.6× 18 0.2× 416 3.8× 34 946
Mercedes García Argentina 12 317 0.7× 38 0.1× 192 0.8× 20 0.2× 98 0.9× 39 447
Christianna Choulaki Greece 9 196 0.5× 40 0.1× 371 1.5× 24 0.2× 31 0.3× 13 575

Countries citing papers authored by Dawn J. Caster

Since Specialization
Citations

This map shows the geographic impact of Dawn J. Caster's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawn J. Caster with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawn J. Caster more than expected).

Fields of papers citing papers by Dawn J. Caster

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawn J. Caster. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawn J. Caster. The network helps show where Dawn J. Caster may publish in the future.

Co-authorship network of co-authors of Dawn J. Caster

This figure shows the co-authorship network connecting the top 25 collaborators of Dawn J. Caster. A scholar is included among the top collaborators of Dawn J. Caster based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawn J. Caster. Dawn J. Caster is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mathis, Steven, Madhavi J. Rane, Michelle T. Barati, et al.. (2025). Serum NF-κB-Regulated Biomarkers of Proliferative Lupus Nephritis. PubMed. 5(1). 328–343. 1 indexed citations
2.
Saxena, Amit, Ellen M. Ginzler, Keisha L. Gibson, et al.. (2023). Safety and Efficacy of Long‐Term Voclosporin Treatment for Lupus Nephritis in the Phase 3 AURORA 2 Clinical Trial. Arthritis & Rheumatology. 76(1). 59–67. 49 indexed citations
3.
Beck, Laurence H., Isabelle Ayoub, Dawn J. Caster, et al.. (2023). KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases. American Journal of Kidney Diseases. 82(2). 121–175. 16 indexed citations
4.
Caster, Dawn J., et al.. (2023). Clinicopathological Characteristics of Adult IgA Nephropathy in the United States. Kidney International Reports. 8(9). 1792–1800. 13 indexed citations
5.
Barati, Michelle T. & Dawn J. Caster. (2022). The Potential of Nrf2 Activation as a Therapeutic Target in Systemic Lupus Erythematosus. Metabolites. 12(2). 151–151. 15 indexed citations
6.
Caster, Dawn J., et al.. (2022). Efficacy and Safety of Immunosuppressive Therapy in Primary Focal Segmental Glomerulosclerosis: A Systematic Review and Meta-analysis. Kidney Medicine. 4(8). 100501–100501. 10 indexed citations
7.
Cummins, Timothy D., David W. Powell, Daniel W. Wilkey, et al.. (2022). Quantitative Mass Spectrometry Normalization in Urine Biomarker Analysis in Nephrotic Syndrome. SHILAP Revista de lepidopterología. 2(3). 121–131. 2 indexed citations
8.
Caster, Dawn J., et al.. (2022). Long-Term Use of Voclosporin in Patients With Class V Lupus Nephritis: Results From the AURORA 2 Continuation Study. Journal of the American Society of Nephrology. 33(11S). 498–498. 2 indexed citations
9.
Caster, Dawn J., et al.. (2022). A Case of Colon Cancer and Pauci-Immune Crescentic Glomerulonephritis. Cureus. 14(7). e27460–e27460. 1 indexed citations
11.
Zhou, Mingqian, Chuanlin Ding, Justin T. Kos, et al.. (2021). Integrin CD11b Negatively Regulates B Cell Receptor Signaling to Shape Humoral Response during Immunization and Autoimmunity. The Journal of Immunology. 207(7). 1785–1797. 3 indexed citations
12.
Caster, Dawn J., et al.. (2020). TNIP1/ABIN1 and lupus nephritis: review. Lupus Science & Medicine. 7(1). e000437–e000437. 17 indexed citations
13.
Merchant, Michael L., Michelle T. Barati, Dawn J. Caster, et al.. (2020). Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis. Journal of the American Society of Nephrology. 31(8). 1883–1904. 26 indexed citations
14.
Caster, Dawn J., Min Tan, Michelle T. Barati, et al.. (2018). Neutrophil exocytosis induces podocyte cytoskeletal reorganization and proteinuria in experimental glomerulonephritis. American Journal of Physiology-Renal Physiology. 315(3). F595–F606. 12 indexed citations
15.
Caster, Dawn J., Michael L. Merchant, Jon B. Klein, & David W. Powell. (2018). Precision medicine in lupus nephritis: can biomarkers get us there?. Translational research. 201. 26–39. 8 indexed citations
16.
Coventry, Susan, et al.. (2018). Hepatitis C mixed cryoglobulinemia with undetectable viral load: A case series. JAAD Case Reports. 4(7). 684–687. 7 indexed citations
17.
Caster, Dawn J., Michelle T. Barati, Min Tan, et al.. (2017). ABIN1 Determines Severity of Glomerulonephritis via Activation of Intrinsic Glomerular Inflammation. American Journal Of Pathology. 187(12). 2799–2810. 13 indexed citations
18.
Barati, Michelle T., et al.. (2016). Characterization of glomerular extracellular matrix by proteomic analysis of laser-captured microdissected glomeruli. Kidney International. 91(2). 501–511. 38 indexed citations
19.
Caster, Dawn J., Michael L. Merchant, Jon B. Klein, et al.. (2015). Autoantibodies targeting glomerular annexin A2 identify patients with proliferative lupus nephritis. PROTEOMICS - CLINICAL APPLICATIONS. 9(11-12). 1012–1020. 33 indexed citations
20.
Caster, Dawn J., James T. Summersgill, Paisit Paueksakon, et al.. (2014). Mixed cryoglobulinemia and secondary membranoproliferative glomerulonephritis associated with ehrlichiosis. CEN Case Reports. 3(2). 178–182. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026